Current neoadjuvant treatment options for HER2 positive breast cancer
Hikmat Abdel-Razeq, Lina MareiSection of Hematology and Medical Oncology, Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanAbstract: Approximately one quarter of patients with breast cancer demonstrate amplification of the human epidermal receptor type 2 (HER2) gene, the exp...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2011
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/fc642340cbf748b88e9d594db1cc3e9c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|